Wyeth To Challenge U.K. Effexor Restrictions

Effective Dec. 6, U.K. labeling for Effexor contraindicates the antidepressant in patients with cardiovascular disease, recommends a baseline ECG for new patients, and restricts prescribing to specialists. Wyeth intends to file a formal appeal of the decision within two weeks.